MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.
about
MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@en
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@nl
type
label
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@en
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@nl
prefLabel
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@en
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@nl
P2093
P2860
P1476
MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.
@en
P2093
Ashwani Kumar Arora
Aurelio Cruz-Valdez
Esther Heijnen
Flavia V Castelli
Gabriel Valdez-Zapata
Marcia G Garcia
Sanjay S Patel
Wim T Jansen
P2860
P304
P356
10.1080/21645515.2017.1373227
P577
2017-09-19T00:00:00Z